Latham Advises on BrightSpring’s Secondary Offering of Common Stock and Concurrent Share Repurchase

BrightSpring Health Services, Inc. (NASDAQ: BTSG) (BrightSpring or the company), a leading home and community-based health services platform, focused on delivering complementary pharmacy and provider services to complex populations, has announced the pricing of an underwritten secondary offering by certain of its stockholders (the selling stockholders), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, of an aggregate 20,000,000 shares of common stock of BrightSpring, at the public offering price of US$41.15 per share. No shares are being sold by BrightSpring in the offering. The selling stockholders will receive all of the proceeds from this offering. The offering is expected to close on March 4, 2026, subject to customary closing conditions.

Latham & Watkins LLP represents the underwriter in the offering with a Capital Markets team led by partners Marc Jaffe, Ian Schuman, and Kaj Nielsen, with associate Molly Mitchell. Advice was also provided on healthcare matters by counsel Nicole Liffrig Molife, with associate Margaret Rote; and on tax matters by partner Elena Romanova, with associate Jack Santoro.